M 14659
Alternative Names: GR 63116; M 14646; M 14648Latest Information Update: 16 Aug 2023
At a glance
- Originator Mochida Pharmaceutical
- Developer Ajinomoto; Mochida Pharmaceutical
- Class Antibacterials; Cephalosporins
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 03 May 1995 Discontinued-I for Bacterial infections in Japan (Parenteral)
- 03 May 1995 Discontinued-Preclinical for Bacterial infections in United Kingdom (Parenteral)